SCHEMBL10282914

SCHEMBL10282914

CS(=O)(=O)N1CCC(N)(c2ccccc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 5/20 0.55
▸ CYP2D6 P10635 6/20 0.54
▸ CYP1A2 P05177 2/20 0.54
▸ HIF1A Q16665 1/20 0.54
▸ CYP3A4 P08684 3/20 0.51
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ ALOX15 P16050 2/20 0.50
▸ OPRD1 P41143 1/20 0.49
▸ OPRK1 P41145 1/20 0.49
▸ USP2 O75604 4/20 0.49
▸ CYP2C19 P33261 3/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ HSD17B10 Q99714 3/20 0.49
▸ HPGD P15428 2/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ TSHR P16473 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13908095 0.83 CYP2C9 (0.42) CYP2C9CYP2D6CYP1A2HIF1ACYP3A4
SCHEMBL13908098 0.81 ALDH1A1 (0.51) CYP2C9CYP2D6CYP3A4MEN1KMT2A
SCHEMBL16644532 0.79 CYP2C19 (0.67) MEN1KMT2ACYP2C19SMN1; SMN2MAPK1
SCHEMBL22874147 0.79 HDAC3 (0.50) CYP2C9CYP3A4MEN1KMT2ACYP2C19
SCHEMBL7066460 0.77 KMT2A (0.70) CYP2C9CYP2D6CYP1A2HIF1ACYP3A4
SCHEMBL56772 0.76 OPRM1 (0.60) CYP2D6OPRD1OPRK1
SCHEMBL24992888 0.76 MEN1 (0.55) CYP2C9CYP2D6CYP1A2HIF1AMEN1
SCHEMBL22874128 0.75 HSD11B1 (0.64) MEN1KMT2ACYP2C19SMN1; SMN2HSD17B10
Sulfuric Acid SCHEMBL3640151 0.74 PNMT (0.43) KMT2AHPGD
SCHEMBL14141340 0.73 PNMT (0.39) CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2420491-A1 3 , 5-substitued piperidine compounds as renin inhibitors Novartis AG (CH) 2012-02-22 — — EP disclosed
Send feedback